Jot Dx ICM Overview
CARDIOVASCULAR
hamburger
Jot Dx ICM

 

INTRODUCING AN ICM THAT IS FOCUSED ON REDUCING 
TIME-CONSUMING DATA BURDEN

Jot Dx™ Insertable Cardiac Monitor (ICM) gives you the power of choice. Reduce your data burden with the Key Episodes* feature turned on; or view all episodes data for those difficult-to-detect arrythmias.

Discover what Jot Dx ICM has to offer by watching our short video below:

 

Jot Dx Insertable Cardiac Monitor (ICM) gives you the precise, actionable EGM insights you need to accurately diagnose difficult-to-detect arrhythmias—including atrial fibrillation.

 

 

 

 

 

 

 

DECREASE YOUR DATA BURDEN

With Key Episodes turned on and the additional Jot Dx ICM pause algorithm improvements, data burden is reduced on average by 63%.1

This translates into valuable time savings of up to 300 hours per 100 patients for Clinic Staff, or 96 hours per 100 patients for the EP.2

Jot Dx ICM

DETECT WITH ACCURACY

Jot Dx ICM with SharpSense™ technology improves accuracy of all episodes by harnessing the power of extra discriminators to confirm or reject detections – significantly improving the accuracy of Atrial Fibrillation, Bradycardia and Pause detected episodes.

SharpSense is responsible for reducing overall false positive detections by 97.8%.3

Jot Dx ICM

Read the recent JCE study which shows how Key Episodes* technology helps to reduce data burden with no delay-to-diagnosis in 99% of patients exhibiting true arrhythmias.4

 

Jot Dx ICM

References:

*Key episodes is a feature of Merlin.net™

  1. EGM Burden Reduction in Jot Dx™ ICM, Technical Development Report System DOC 90805939 Rev A.
  2. HRS 2021 Poster - Reducing Clinical Review Burden of Insertable Cardiac Monitors In Patients with Frequent Arrhythmia Detections
  3. CONFIRM Rx™ ICM With SharpSense™ Technology Reduces False Positives, the Number of Episodes Stored and Episodes Transmitted: Results of a Multicenter Retrospective Analysis, 2019
  4. Gardner RS, Quartieri F, Betts TR, et al. Reducing the electrogram review burden imposed by insertable cardiac monitors. Journal of cardiovascular electrophysiology. 2022;33(4):741-750. doi:10.1111/jce.15397

Additional References

  1. Ip J, Jaffe B, Castellani M, Sheikh A, Castellani C, Ip R. Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx. Pacing & Clinical Electrophysiology. 2020;43(11):1344-1350. doi:10.1111/pace.14076
  2. Piorkowski C, Manyam H, Lakkireddy D, et al. Effectiveness and performance of Confirm Rx SharpSense Technology: A Multi-center Retrospective Analysis. Presented at Asia Pacific Heart Rhythm Society (APHRS); Bangkok, Thailand; Oct 27-29, 2019.

™ Indicates a trademark of the Abbott group of companies.

Sign Up for Updates

MAT-2108238 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.